Research Article

An Evaluation of Chronic Hepatitis C Patients’ Responses to Direct-Acting Antivirals According to Transient Elastography and Serum Biomarkers
  • Nurten Nur Aydın
  • İftihar Köksal
Viral Hepat J 2022; 28: 18-24 DOI: 10.4274/vhd.galenos.2022.2021-8-2
Evaluation of HCV-Core Antigen in Diagnosis of Chronic Hepatitis C Patients under Direct-Acting Antiviral Treatment
  • Müge Toygar Deniz
  • Sıla Akhan
  • Murat Sayan
  • Gülden Sönmez Tamer
  • Emel Azak
Viral Hepat J 2022; 28: 25-31 DOI: 10.4274/vhd.galenos.2022.2021-3-2
Direct-acting Antiviral Agents in Patients with Chronic Hepatitis C: Real-life Data
  • Ayhan Balkan
  • Yasemin Balkan
  • Abdullah Emre Yıldırım
  • Buğra Tolga Konduk
  • Sezgin Barutçu
  • Abdülkadir Daldal
  • Kenan Uğurlu
  • Mustafa Seyyar
  • Mustafa Namıduru
  • Taylan Metin
  • Murat Taner Gülşen
Viral Hepat J 2021; 27: 42-48 DOI: 10.4274/vhd.galenos.2021.2020-11-1
Long-term Kinetics of Alpha-fetoprotein in Chronic Hepatitis C Patients Treated with Direct-acting Antivirals and Possible Predictive Role of AFP Response to Treatment on Development of Hepatocellular Carcinoma
  • Celal Ulaşoğlu
  • Banu Erkalma Şenateş
  • Suna Yapalı
  • Betül Dumanoğlu
  • Feruze Enc
  • Yaşar Çolak
  • Ebubekir Şenateş
Viral Hepat J 2021; 27: 49-52 DOI: 10.4274/vhd.galenos.2021.2021-5-3
Direct-acting Antiviral Therapy for Mixed Genotype Chronic Hepatitis C Infection
  • Bedia Mutay Suntur
  • Nevzat Ünal
  • Hava Kaya
  • Banu Kara
  • Halime Betül Şahin Eker
Viral Hepat J 2019; 25: 55-58 DOI: 10.4274/vhd.galenos.2019.2019.0013
Intravenous Drug Use Rates and Results of Direct-acting Antiviral Treatment in Prisoner Patients
  • Mehmet Çabalak
  • Tayibe Bal
Viral Hepat J 2020; 26: 61-64 DOI: 10.4274/vhd.galenos.2020.2020.0015
Evaluation of Direct-acting Antiviral Agents and Clinical Responses in Chronic Hepatitis C Patients
  • Esra Zerdalı
  • İnci Yılmaz Nakir
  • Filiz Pehlivanoğlu
Viral Hepat J 2022; 28: 79-84 DOI: 10.4274/vhd.galenos.2022.2022-4-2
Post-Treatment Course of Indices Predicting Liver Fibrosis in Adult Chronic Hepatitis C Patients Treated with Direct-Acting Antivirals
  • Ahmet Sertçelik
  • İmran Hasanoğlu
  • Ayşe Kaya Kalem
  • Rahmet Güner
Viral Hepat J 2023; 29: 81-86 DOI: 10.4274/vhd.galenos.2023.2023-8-5
Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data
  • Ayla Doğrugörün
  • Elif Doyuk Kartal
  • Saygın Nayman Alpat
Viral Hepat J 2023; 29: 95-100 DOI: 10.4274/vhd.galenos.2023.2023-6-1
Early Viral Kinetics in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals
  • Dilruba Garashova
  • İlker İnanç Balkan
  • Reşat Özaras
  • Mert Ahmet Kuşkucu
  • Ayşenur Özdil
  • Khalis Mustafayev
  • Sibel Yıldız Kaya
  • Rıdvan Karaali
  • Bilgül Mete
  • Gökhan Aygün
  • Neşe Saltoğlu
  • Ömer Fehmi Tabak
Viral Hepat J 2023; 29: 101-107 DOI: 10.4274/vhd.galenos.2023.2023-12-1
Efficacy of Direct-acting Antivirals in Hemodialysis Patients with Chronic Hepatitis C: A Real-life Retrospective Study
  • Nurten Nur Aydın
  • Firdevs Aksoy
  • İlknur Yavuz
  • Serap İskender
  • Arzu Altunçekiç Yıldırım
  • İlknur Esen Yıldız
  • İftihar Köksal
Viral Hepat J 2019; 25: 105-108 DOI: 10.4274/vhd.galenos.2019.2019.0025
The Treatment of Ledipasvir/Sofosbuvir in Patients with Chronic Hepatitis C Virus: The Results of Five-year Follow-up
  • Murat Pekgöz
  • Nevin İnce
Viral Hepat J 2021; 27: 124-130 DOI: 10.4274/vhd.galenos.2021.2021-6-1

Case Report

Non-hodgkin Lymphoma Developing After Discontinuation of Direct-acting Antiviral Treatment for Hepatitis C: A Case Report
  • Oğuz Karabay
  • Ertuğrul Güçlü
  • Tuba Hacıbekiroğlu
  • Mustafa Kösem
Viral Hepat J 2019; 25: 32-34 DOI: 10.4274/vhd.galenos.2018.0029
Failure of Direct-Acting Antiviral Agents Due to Incomplete Hepatitis C Virus Genotyping
  • Esragül AKINCI
  • Esra YURDCU
  • Bahadır ORKUN ÖZBAY
  • Hürrem BODUR
Viral Hepat J 2018; 24: 96-98 DOI: 10.4274/vhd.2018.0022

Review

Drug Resistance to HCV in Direct-Acting Antiviral Treatments
  • Murat Sayan
Viral Hepat J 2023; 29: 90-94 DOI: 10.4274/vhd.galenos.2023.2023-8-4